1. Kondo T, Nakano Y, Adachi S, Murohara T. Effects of Tobacco Smoking on Cardiovascular Disease. Circulation Journal, 2019;83(10):1980-5. doi:10.1253/circj.CJ-19-0323.
2. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). European Heart Journal, 2021;34(42):3227- 337. doi:10.1093/eurheartj/ehab484.
3. Драпкина О.М., Концевая А.В., Калинина А.М. и др. Профилактика хронических неинфекционных заболеваний в Российской Федерации. Национальное руководство 2022. Кардиоваскулярная терапия и профилактика. 2022;21(4):3235. doi:10.15829/1728-8800-2022-3235.
4. Golbidi S, Edvinsson L, Laher I. Smoking and Endothelial Dysfunction. Current Vascular Pharmacology, 2020;18(1):1-11. doi:10.2174/1573403X14666180913120015.
5. Wang W, Zhao T, Geng K, et al. Smoking and the Pathophysiology of Peripheral Artery Disease. Frontiers in Cardiovascular Medicine. 2021;8:704106. doi:10.3389/fcvm.2021.704106.
6. Akkus F, Terbeck S, Haggarty CJ, et al. The role of the metabotropic glutamate receptor 5 in nicotine addiction. CNS Spectrums, 2021;26(6):601-6. doi:10.1017/S1092852920001704.
7. Boffo M, Zerhouni O, Gronau QF, et al. Cognitive Bias Modification for Behavior Change in Alcohol and Smoking Addiction: Bayesian Meta-Analysis of Individual Participant Data. Neuropsychology Review. 2019;29:52-78. doi:10.1007/s11065-018-9386-4.
8. Ranjit A, Korhonen T, Buchwald J, et al. Testing the reciprocal association between smoking and depressive symptoms from adolescence to adulthood: A longitudinal twin study. Drug and Alcohol Dependence. 2019;200:64-70. doi:10.1016/j.drugalcdep.2019.03.012.
9. Odorico M, Le Goff D, Aerts N, et al. How To Support Smoking Cessation In Primary Care And The Community: A Systematic Review Of Interventions For The Prevention Of Cardiovascular Diseases. Vascular Health Risk Management. 2019;15:485-502. doi:10.2147/VHRM.S221744.
10. Vilardaga R, Casellas-Pujol E, McClernon JF, et al. Mobile Applications for the Treatment of Tobacco Use and Dependence. Current Addiction Reports. 2019;6:86-97. doi:10.1007/s40429-019-00248-0.
11. Таратухин Е.О. Пациент-центрированная медицина. Новая реальность. Российский кардиологический журнал. 2016;(9):79-83. doi:10.15829/1560-4071-2016-9-79-83.
12. Rajani NB, Weth D, Mastellos N, Filippidis FT. Adherence of popular smoking cessation mobile applications to evidence-based guidelines. BMC public health. 2019;19(1):743. doi:10.1186/s12889-019-7084-7.
13. Hartmann-Boyce J, Livingstone-Banks J, Ordóñez-Mena JM, et al. Behavioural interventions for smoking cessation: an overview and network meta‐analysis. Cochrane Database of Systematic Reviews, 2021;1:CD013229. doi:10.1002/14651858.CD013229.pub2.
14. Whittaker R, McRobbie H, Bullen C, et al. Mobile phone text messaging and app‐based interventions for smoking cessation. Cochrane Database of Systematic Reviews 2019, Issue 10. Art. No.: CD006611. doi:10.1002/14651858.CD006611.pub5.
15. Колпакова О.И., Любимова А.И. (2016). Перспективы использования в России мобильных приложений, помогающих молодежи отказаться от курения. Теория и практика общественного развития. 2016;(10):27-31.
16. Горный Б.Э., Бунова А.С., Кушунина Д.В. и др. Оценка русскоязычных мобильных приложений, предназначенных для поддержки отказа от курения. Профилактическая медицина. 2022;25(7):66-72. doi:10.17116/profmed20222507166.
17. Stoyanov SR, Hides L, Kavanagh DJ, et al. Mobile App Rating Scale: A New Tool for Assessing the Quality of Health Mobile Apps. JMIR Mhealth Uhealth. 2015;3(1):e27. doi:10.2196/mhealth.3422.